Haematology / Oncology A
NCI CTCAE Mucositis Grading
NCI Common Terminology Criteria for Adverse Events (CTCAE v5.0) grading for oral mucositis. Used to standardise reporting and guide management decisions in oncology patients.
References
- National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017.
- Elad S, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126(19):4423-4431.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Folinic Acid (Calcium Folinate / Leucovorin) · Antidote / Chemotherapy Support
- Zoledronic Acid · Bisphosphonate (IV)
- Denosumab · RANK Ligand Inhibitor (Anti-resorptive)
- Cisplatin · Platinum Chemotherapy — Head and Neck Cancer
- Methotrexate · Chemotherapy / Immunosuppressant — Head and Neck / Granulomatosis
- Zoledronic Acid · IV Bisphosphonate
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.